The Weekly Litigation News Digest is now live. Subscribe now

Pentafarma competitive analysis

Loading summary...

Explore patent oppositions filed by Pentafarma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICAAug 19, 2019
Use Of Polyols To Obtain Stable Polymorphous Forms Of RifaximinALFASIGMAJan 19, 2018
(Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved StabilitySANOFIJan 4, 2018

Latest PTAB cases involving Pentafarma

Discover the latest PTAB cases involving Pentafarma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pentafarma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PENTAFARMA SOCIEDADE TECNICO MEDICINAL1 - - -
SANOFI5923 - -
SANOFI AVENTIS DEUTSCHLAND1630 - 24